Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Preventive Medicine Reports|August 14, 2023
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshopAnne E Schuind, Helen Rees, John Schiller, et al.
The Lancet. Infectious Diseases|December 4, 2018
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trialSinead Delany-Moretlwe, Carl Lombard, Deborah Baron, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
The New England Journal of Medicine|June 23, 2021
SARS-CoV-2 Variants and VaccinesPhilip R Krause, Thomas R Fleming, Ira M Longini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2024
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelinesRaquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, et al.
Journal of Pediatric Surgery|April 29, 2026
Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European paediatric Soft-tissue sarcoma Study Group (EpSSG)Naima Smeulders, Mark N Gaze, Florent Guérin, et al.
The Lancet. Respiratory Medicine|July 6, 2025
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trialsRichard G White, Gavin J Churchyard, Katherine C Horton, et al.
Cancers|March 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Cancers|October 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Plos Medicine|January 23, 2015
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisCharles S Morrison, Pai-Lien Chen, Cynthia Kwok, et al.
Pageof 17